Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
20D9-ADC
i
Other names:
20D9-ADC
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Tubulis
Drug class:
FLT3-targeted antibody-drug conjugate
Related drugs:
‹
AGS62P1 (1)
AGS62P1 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
midostaurin + 20D9-ADC
Sensitive: D – Preclinical
midostaurin + 20D9-ADC
Sensitive
:
D
midostaurin + 20D9-ADC
Sensitive: D – Preclinical
midostaurin + 20D9-ADC
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.